A universal virus-like particle-based vaccine for human papillomavirus: longevity of protection and role of endogenous and exogenous adjuvants.
about
Preparation by alkaline treatment and detailed characterisation of empty hepatitis B virus core particles for vaccine and gene therapy applications.Capsid display of a conserved human papillomavirus L2 peptide in the adenovirus 5 hexon protein: a candidate prophylactic hpv vaccine approachA vaccine of L2 epitope repeats fused with a modified IgG1 Fc induced cross-neutralizing antibodies and protective immunity against divergent human papillomavirus types.VLP-based vaccine induces immune control of Staphylococcus aureus virulence regulation.Immunization with a consensus epitope from human papillomavirus L2 induces antibodies that are broadly neutralizingA chimeric 18L1-45RG1 virus-like particle vaccine cross-protects against oncogenic alpha-7 human papillomavirus types.A malaria vaccine candidate based on an epitope of the Plasmodium falciparum RH5 protein.Identification of Broad-Genotype HPV L2 Neutralization Site for Pan-HPV Vaccine Development by a Cross-Neutralizing Antibody.Second-generation prophylactic HPV vaccines: successes and challenges.Affinity selection of epitope-based vaccines using a bacteriophage virus-like particle platformPreclinical refinements of a broadly protective VLP-based HPV vaccine targeting the minor capsid protein, L2Epitope-Specific Anti-hCG Vaccines on a Virus Like Particle Platform.Malaria invasion ligand RH5 and its prime candidacy in blood-stage malaria vaccine designImmunological Characterization of Plant-Based HIV-1 Gag/Dgp41 Virus-Like Particles.Chimeric L2-Based Virus-Like Particle (VLP) Vaccines Targeting Cutaneous Human Papillomaviruses (HPV)Optimized Formulation of a Thermostable Spray-Dried Virus-Like Particle Vaccine against Human PapillomavirusProgress and prospects for L2-based human papillomavirus vaccinesEngineering virus-like particles as vaccine platformsRecent progress in vaccination against human papillomavirus-mediated cervical cancer.Construction of random tumor transcriptome expression library for creating and selecting novel tumor antigens.Characterization of a spray-dried candidate HPV L2-VLP vaccine stored for multiple years at room temperature.Cationic domains in particle-forming and assembly-deficient HBV core antigens capture mammalian RNA that stimulates Th1-biased antibody responses by DNA vaccination
P2860
Q27308848-F7D131CA-5802-4728-9AA2-3DB28A39615AQ28607775-DACBBAC0-EEB6-4F32-96E5-70ED11DE6578Q33572691-352D4499-3AEB-4EC5-B00E-5DF04CC1C8F4Q33677615-AD4A2CE9-D7AE-4CE4-A19C-728225B6B46BQ33967341-370213E5-B687-4282-B081-9989F6162CCBQ35196119-E0F812FF-A82B-460F-B5FD-15E5A960F400Q35227478-12C47536-5E4E-4301-822E-BBBBB8BAA452Q35532771-F04B4620-6FC1-4CA8-AFF8-3952067D4858Q35541886-DA443173-43AB-4A23-B95C-B4FAB2664797Q35591551-C46A2F90-D4F1-4581-932F-6366B3CC7464Q35744303-25C74261-4E7E-4859-95F9-BD4834A8CA1BQ35827034-0523F985-F12A-4000-9AEA-D2EF02572113Q35887367-8A7D86BA-F362-4FB7-A82A-F88D22F48E18Q35960908-115A93E7-7DD3-4EBC-96BE-E4AF508F99A6Q36240497-49E5A997-EA38-4FFD-8A7C-AF2072627F08Q36858686-19E9BC43-A232-403D-9F3E-4AD372EBF2A8Q37014047-62C1252C-C89C-4493-81E0-8FD298FB5901Q37172342-92444294-BDF0-4AF9-BDFA-46E5686FCD03Q38370782-C7E5A5B2-8401-4557-AE45-9998F2903753Q38736887-2AD04A44-C9B1-460F-A529-19B2EE73F41BQ40117882-16CCE3F7-0282-4D99-99C6-5C36029FDC8FQ57050439-5E2E8AB5-2D54-4783-9B4B-45C715E434C6
P2860
A universal virus-like particle-based vaccine for human papillomavirus: longevity of protection and role of endogenous and exogenous adjuvants.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 09 August 2013
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
A universal virus-like particl ...... enous and exogenous adjuvants.
@en
A universal virus-like particl ...... enous and exogenous adjuvants.
@nl
type
label
A universal virus-like particl ...... enous and exogenous adjuvants.
@en
A universal virus-like particl ...... enous and exogenous adjuvants.
@nl
prefLabel
A universal virus-like particl ...... enous and exogenous adjuvants.
@en
A universal virus-like particl ...... enous and exogenous adjuvants.
@nl
P2093
P2860
P1433
P1476
A universal virus-like particl ...... enous and exogenous adjuvants.
@en
P2093
Bryce Chackerian
David S Peabody
Ebenezer Tumban
Julianne Peabody
P2860
P304
P356
10.1016/J.VACCINE.2013.07.052
P407
P577
2013-08-09T00:00:00Z